MHRA approves remibrutinib for adults with chronic spontaneous urticaria
As with any medicinal product, the MHRA will keep the safety and effectiveness of remibrutinib under close review.
C Lino
Editor & Founder | SalisburyPost Passionate about local journalism, I am dedicated to delivering trusted news and strengthening connections across Salisbury and Wiltshire. Through SalisburyPost, I aim to keep residents informed, celebrate community achievements, and highlight the stories that matter most to local people.
Comments (0)